Pediatric Cancer
The Pediatric Cancer Research Group (PCRG) is a multidisciplinary team of scientists working to improve the outcomes of children diagnosed with cancer by combining the scientific infrastructure of the University of Nebraska Medical Center and the Fred & Pamela Buffet Cancer Center with the resources and clinical expertise of Children’s Hospital & Medical Center.
The PCRG is the pediatric cancer CHRI area of emphasis (AOE), and its efforts span:
- Epidemiology and prevention, including extensive research into water quality as it relates to pediatric cancer rates in Nebraska and other rural areas
- Pathology of different cancers/tumors, including medulloblastoma, neuroblastoma, hematological malignancies and more
- Innovative treatments with collaborators from pharmaceutical sciences and increased infrastructure to conduct clinical trials, including augmenting data management
- Quality of care research, such as the use of robotics and virtual reality to improve experiences in physical therapy or decrease the need for sedation in radiation oncology and imaging
- Survivorship research in partnership with Children’s Hospital & Medical Center Survivorship Clinic
- Developing resources and tools to benefit a wide range of cancer research, including animal models and tumor banks
- Training for the next generation of researchers through fellowships and laboratory experiences
If you are a CHRI member and would like to join the Pediatric Cancer area of emphasis, please email chri@unmc.edu.
Funding through the PCRG
- In early 2014, LB 764 was introduced by State Senator Danielle Conrad to appropriate $1.8M from the General Fund for pediatric cancer research infrastructure at the University of Nebraska.
- In early 2015, LB 417 was introduced by State Senators Nordquist and Mello and subsequently approved to continue appropriations of $1.8M per year (with $300K per year reserved for neuro-oncology) in perpetuity.
To submit an application or ask a question contact: PCRG Program Director, Don Coulter, MD dwcoulter@unmc.edu. Applications are accepted throughout the year.
Co-Champions

Director for Research, Pediatric Critical Care Medicine Associate Professor, Department of Pediatrics Associate Professor, Department of Biochemistry

Medulloblastoma Collaborative
Vision:
To improve the life of children with high-risk medulloblastomas
Mission:
To capitalize on complementary biomedical expertise within CHRI and the greater University of Nebraska campuses to collaboratively advance our understanding of high-risk medulloblastoma pathophysiology and therapeutics
Goals:
- To allow for free exchange of ideas that may result in better quality research
- To provide a panel of MB experts who may provide peer review for future projects, manuscripts and grants
- To eventually procure multi-PI national funding
Members
![]() |
![]() |
Kishor Bhakat, PhD, Scientist Associate Professor, Department of Genetics, Cell Biology and Anatomy |
Nagendra Chaturvedi, PhD, Scientist Assistant Professor and Research Scientist, Division of Hematology/Oncology |
![]() |
![]() |
Don Coulter, MD, Hematologist Professor, Division of Pediatric Hematology/Oncology |
Arnett Klugh, MD, Neurosurgeon Associate Professor of Neurosurgery |
![]() |
![]() |
Sidharth Mahapatra, MD, PhD, Critical Care Clinician and Scientist Associate Professor, Department of Pediatrics |
Ram I. Mahato, PhD, Scientist Chair and Professor of Pharmaceutical Sciences |
![]() |
![]() |
Aaron Mohs, PhD Associate Professor, Department of Pharmaceutical Sciences |
Sutapa Ray, PhD, Scientist Assistant Professor, Department of Pediatrics |
![]() |
![]() |
Angie Rizzino, PhD, Scientist Professor, Eppley Institute |
Afshin Salehi, MD, MS, Neurosurgeon Assistant Professor of Neurosurgery |
![]() |
|
Paul Trippier, PhD Associate Professor and Director, Pharmaceutical Sciences Graduate Program |
Hematological Malignancies Subgroup
Goals:
- Increase communication between clinical, translational, and basic science researchers
- Provide resources for group members
- Promote new research projects- particularly those in line with the pediatric patient population in Omaha
Members
![]() |
![]() |
Melissa Acquazzino, MD |
Hamid Band, MD, PhD |
![]() |
![]() |
Jill Beck, MD |
Shannon Buckley, PhD |
![]() |
![]() |
Dalia Elgamal, PhD |
James B. Ford, DO |
![]() |
![]() |
Jordan Fritch |
Kyle Hewitt, PhD |
|
|
![]() |
![]() |
Kate Hyde, PhD |
Javeed Iqbal, PhD |
|
|
![]() |
![]() |
Shantaram Joshi, PhD |
So-Youn Kim, PhD |
![]() |
![]() |
Taylor Losole, MD |
Aaron Mohs, PhD |
|
|
![]() |
![]() |
Grace Murray, MD Hematology/Oncology Fellow |
DJ Murry, PharmD Professor, Department of Pharmacy Practice and Science |
![]() |
![]() |
Sachit Patel, MD |
Chittalsinh Raulji, MBBS |
|
|
![]() |
![]() |
Sutapa Ray, PhD |
Jordan Rowley, PhD |
|
|
![]() |
|
Paul Trippier, PhD |